NASDAQ
Antisense Therapeutics Limited (ATHJF) has a free cash flow growth of -10.86% as of Friday, May 29, 2026. This represents a 47.89% increase compared to its 12-month average of -20.85%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.